Volume 2, Number 4—October 1996
Dispatch
Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model
Table 2
Baiting scenario | NPV without pet vaccination ($ millions) |
NPV with pet vaccinationsa
($ millions) |
||||||
---|---|---|---|---|---|---|---|---|
Discount rate |
Discount rate |
|||||||
0% | 3% | 5% | 0% | 3% | 5% | |||
Expanding circlesb | -10.2 | -6.2 | -4.7 | +5.5 | +3.1 | +2.2 | ||
Entire area at onceb | -21.3 | -15.7 | -13.3 | -0.5 | -1.1 | -1.3 | ||
Sensitivity analyses | ||||||||
Reduced distribution:savingsc | ||||||||
Expanding circles | -14.3 | -8.5 | -6.3 | +1.4 | +0.9 | +0.6 | ||
Entire area done at once | -30.8 | -21.9 | -18.2 | -12.5 | -8.9 | -7.3 | ||
No baiting of boundary | ||||||||
Expanding circles | -0.7 | -1.8 | -2.1 | +14.1 | +7.9 | +4.5 | ||
Entire area at once | +2.9 | -0.9 | -2.3 | +23.7 | +13.7 | +9.7 |
a) Cost savings (benefits) of 11 pets/sq. mi during an epizootic period, and 2.75 pets/sq. mi during the post-epizootic period, both at $16/pet.
b) Expanding circles assumes start with 20-mi radius, expanding by 5 mi every 2 years for 20 years, and then baiting a 5-mi wide boundary for next 10 years. Entire area assumes baiting 65-mi radius for 2 years, followed by 28 years of baiting 5-mi wide radius.
c) Ratio of distribution costs:cost savings is 1:1.03,based on New Jersey data (1). In baseline scenario, ratio is 1:1.57.
References
- Rupprecht CE, Smith JS. Raccoon rabies—the re-emergence of an epizootic in a densely populated area. Semin Virol. 1994;5:155–64. DOIGoogle Scholar
- Krebs JW, Strine TW, Smith JS, Rupprecht CE, Childs JE. Rabies surveillance in the United States during 1993. J Am Vet Med Assoc. 1994;205:1695–709.PubMedGoogle Scholar
- Centers for Disease Control and Prevention. Rabies postexposure prophylaxis—Connecticut, 1990-1994. MMWR Morb Mortal Wkly Rep. 1996;45:232–4.PubMedGoogle Scholar
- Centers for Disease Control and Prevention. Animal rabies—South Dakota, 1995. MMWR Morb Mortal Wkly Rep. 1996;45:164–6.PubMedGoogle Scholar
- Uhaa IJ, Dato VM, Sorhage FE, Beckly JW, Roscoe DE, Gorsky RD, Benefits and costs of using an orally absorbed vaccine to control rabies in raccoons. J Am Vet Med Assoc. 1992;201:1873–82.PubMedGoogle Scholar
- Winkler WG, Bogel K. Control of rabies in wildlife. Sci Am. 1992; (
June ):86–92. DOIPubMedGoogle Scholar - Rupprecht CE, Smith JS, Fekadu M, Childs JE. The ascension of wildlife rabies: A cause for public health concern or intervention? Emerg Infect Dis. 1995;1:107–14. DOIPubMedGoogle Scholar
- Steck F, Wandler A, Bischel P, Capt S, Hafliger U, Schneider L. Oral immunization of foxes against rabies. Laboratory and field studies. Comp Immunol Microbiol Infect Dis. 1982;5:165–79. DOIPubMedGoogle Scholar
- Rupprecht CE, Wiktor TJ, Johnson DH, Hamir AN, Dietzschold B, Wunner Wh, et al. Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proc Natl Acad Sci U S A. 1986;83:7947–50. DOIPubMedGoogle Scholar
- Robbins AH, Niezgoda M, Levine S, Windmiller BS, McGuill MW, Rowell SL, Oral rabies vaccination of raccoons (Procyon lotor) on the Cape Cod isthmus, Massachusetts. Presented at the 5th Annual International Meeting of Rabies in the Americas, Niagara Falls, Ontario, Canada, 1994; Conference Abstracts, p.29.
- Hanlon CA, Trimarchi CE, Rupprecht CE, Debbie JG. Oral wildlife rabies vaccination in New York state: First field evaluation in an enzootic raccoon rabies area. Presented at the 6th Annual International Meeting on Research Advances and Rabies Control in the Americas, Merida, Mexico, 1995; Program and Abstracts, p.29.
- Manning A. Texas officials take battle against rabies to the air. USA Today January 11, 1996:27.
- Slate D, Calvert RT, Chipman RB, Barden ME. Raccoon pest management patterns before, during and after a rabies epizootic in northern New England: What do they mean? Presented at the 6th Annual International Meeting on Research Advances and Rabies Control in the Americas, Merida, Mexico; 1995; Program and Abstracts, p.20.
- Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost effectiveness in health and medicine. New York: Oxford University Press, 1996.
- Haddix AC, Teutsch SM, Shaffer PA, Dunet DO, eds. Prevention effectiveness: A guide to decision analysis and economic evaluation. New York: Oxford University Press, 1996.
- Perry BD, Garner N, Jenkins SR, McCloskey K, Johnston DH. A study of techniques for the distribution of oral rabies vaccine to wild raccoon populations. J Wildl Dis. 1989;25:206–17.PubMedGoogle Scholar
- Linhart SB, Blom FS, Engeman RM, Hill HL, Hon T, Hall DI, A field evaluation of baits for delivering oral rabies vaccines to raccoons (Procyon lotor). J Wildl Dis. 1994;30:185–94.PubMedGoogle Scholar
- Hanlon CL, Hayes DE, Hamir AN, Snyder DE, Jenkins S, Hable CP, Proposed field evaluation of a rabies recombinant vaccine for raccoons (Procyon lotor): sites election, target species characteristics, and placebo baiting trials. J Wildl Dis. 1989;25:555–67.PubMedGoogle Scholar
- Hoffmann CO, Gottschang JL. Numbers, distribution, and movements of a raccoon population in a suburban residential community. J Mammal. 1977;58:623–36. DOIGoogle Scholar
- Hudson EM. The raccoon (Procyon lotor) on St. Catherines Island, Georgia: Part 2: Relative abundance in different forest types as a function of population density. American Musgum Novitates 1978;1-16.
- Population Estimates and Population Distribution Branches, Division of Population, U.S. Bureau of the Census. Estimates of the resident population of states and counties, and percent change 4/1/90 to 7/1/94. Posted on the Internet: 1995 Jan 18.
- American Veterinary Medical Association. US pet ownership and demographics source book. Schaumburg, IL: American Veterinary Medical Association, 1995.
Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.